triiodothyronine has been researched along with Fatigue Syndrome, Chronic in 3 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, M | 1 |
| Miranda-Massari, JR | 1 |
| Gonzalez, MJ | 1 |
| Rosenhagen, MC | 1 |
| Schmidt, U | 1 |
| Ebinger, M | 1 |
| Nickel, T | 1 |
| Uhr, M | 1 |
| Weetman, AP | 1 |
2 reviews available for triiodothyronine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Supraphysiological cyclic dosing of sustained release T3 in order to reset low basal body temperature.
Topics: Body Temperature; Delayed-Action Preparations; Drug Administration Schedule; Fatigue Syndrome, Chron | 2006 |
Thyroxine treatment in biochemically euthyroid but clinically hypothyroid individuals.
Topics: Depressive Disorder; Diagnosis, Differential; Fatigue Syndrome, Chronic; Humans; Hypothyroidism; Mid | 2002 |
1 other study available for triiodothyronine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Successful treatment of chronic fatigue syndrome with duloxetine and trijodthyronine--a case study.
Topics: Adult; Drug Therapy, Combination; Duloxetine Hydrochloride; Fatigue Syndrome, Chronic; Female; Human | 2008 |